✦ LIBER ✦

Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer

✍ Scribed by Kumar Rajagopalan; David Peereboom; G. Thomas Budd; Thomas Olencki; Siva Murthy; Paul Elson; Denise McLain; Ronald Bukowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review of phase II hormone refractory pr

✍ Gerald P Murphy 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase II study of topotecan in metastati

✍ Gary R. Hudes; Richard Kosierowski; Richard Greenberg; Harry E. Ramsey; Stephen 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 562 KB

A phase II trial of gefitinib in patient

✍ Eric J. Small; Joseph Fontana; Nizar Tannir; Robert S. DiPaola; George Wilding; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

A phase II trial of irinotecan in hormon

✍ David M. Reese; Simon Tchekmedyian; Yvonne Chapman; Diane Prager; Peter J. Rosen 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 67 KB

Phase II Trial of Docetaxel/Capecitabine

✍ Michael Kolodziej; Marcus A. Neubauer; Steven R. Rousey; Robert E. Pluenneke; Ge 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Phase II evaluation of didemnin B in hor

✍ Stephen K. Williamson; Michael K. Wolf; Mario A. Eisenberger; Mark O'Rourke; Wil 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 302 KB